Familial clustering of chronic kidney disease

Seminars in Dialysis

Volumn 20, Issue 3, 2007, Pages 229-236

  Satko, Scott G ^a   Sedor, John R ^b   Iyengar, Sudha K ^c   Freedman, Barry I ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; DIABETIC NEPHROPATHY; EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETICS; HEALTH; HUMAN; KIDNEY DISEASE; MASS SCREENING; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY;

CARDIOVASCULAR DISEASES; CAUSALITY; CHRONIC DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KIDNEY DISEASES; MASS SCREENING; OBESITY; WORLD HEALTH;

EID: 34250009614     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2007.00282.x     Document Type: Article

References (81)

1. U.S. Renal Data Systems : USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD : National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2006. http://www.usrds.org/adr.htm (Report)
2. International Federation of Renal Registries : International Database, 2006. http://www.ifrr.net (Report), accessed March 15, 2007
3. Societa' Italiana Di Neprologia: Registro Italiano Dialisi E Trapianto, 2006. http://www.sin-ridt.org.sin-ridt.org.htm (Report), accessed March 15, 2007
4. The Renal Association : United Kingdom Renal Registry Report, 2005. http://www.renalreg.com (Report), accessed March 15, 2007
5. Turkish Society of Nephrology: Registry of Nephrology, Dialysis and Transplantation in Turkey, 2004. http://www.tsn.org.tr/registry_en.asp (Report)
6. Australia and New Zealand Dialysis and Transplantation Registry: The 28th Annual Report, 2005. http://www.anzdata.org.au (Report), accessed March 15, 2007
7. Mainous AG, Baker R, Koopman RJ, Saxena S, Diaz VA, Everett CJ, Majeed A : Impact of the population at risk of diabetes on projections of diabetes burden in the United States: an epidemic on the way. Diabetologia Epub ahead of print: Nov 21, 2006
8. Elbein SC : The genetics of human noninsulin-dependent (type2) diabetes mellitus. J Nutr 127 : 1891S 1896S, 1997
9. Sale MM, Freedman BI : Genetics of albuminuria and renal disease in diabetes mellitus. Nephrol Dial Transplant 21 : 13 16, 2006
10. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Saint J, Helgason A, Stefansson H, Emilsson V, Helgadottir A, Styrkarsdottir U, Magnusson KP, Walters GB, Palsdottir E, Jonsdottir T, Gudmundsdottir T, Gylfason A, Saemundsdottir J, Wilensky RL, Reilly MP, Radar DJ, Bagger Y, Christiansen C, Gudnason V, Sigurdsson G, Thorsteinsdottir U, Gulcher JR, Kong A, Stefansson K : Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38 : 320 323, 2006
11. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, Lane CR, Schaffner SF, Bolk S, Brewer C, Tuomi T, Gaudet D, Hudson TJ, Daly M, Groop L, Lander ES : The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26 : 76 80, 2000
12. Gloyn AL, Weedon MN, Owen KR, Turner MJ, Knight BA, Hitman G, Walker M, Levy JC, Sampson M, Halford S, McCarthy MI, Hattersley AT, Frayling TM : Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23 K variant is associated with type 2 diabetes. Diabetes 52 : 568 572, 2003
13. Florez JC, Jablonski KA, Bayley N, Pollin TI, de Bakker PI, Shuldiner AR, Knowler WC, Nathan DM, Altshuler D, Diabetes Prevention Program Research Group : TCF7L2 polymorphis and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 355 : 241 250, 2006
14. Weedon MN, McCarthy MI, Hitman G, Walker M, Groves CJ : Combining information from common type 2 diabetes risk polymorphisms improves disease prediction. PLoS Med 3 : e374, 2006
15. Forsblom CM, Kanninen T, Lehtovirta M, Saloranta C, Groop LC : Heritability of albumin excretion rate in families of patients with Type II diabetes. Diabetologia 42 : 1359 1366, 1999
16. Fogarty DG, Rich SS, Hanna LS, Warram JH, Krolewski AS : Urinary albumin excretion in families with type 2 diabetes is heritable and genetically correlated to blood pressure. Kidney Int 57 : 250 257, 2000
17. Langefeld CD, Beck SR, Bowden DW, Rich SS, Wagenknecht LE, Freedman BI : Heritability of GFR and albuminuria in Caucasians with type 2 diabetes mellitus. Am J Kidney Dis 5 : 796 800, 2004
18. Krolewski AS, Poznik GD, Placha G, Canni L, Dunn J, Walker W, Smiles A, Krolewski B, Fogarty DG, Moczulski D, Araki S, Makita Y, Ng DP, Rogus J, Duggirala R, Rich SS, Warram JH : A genome-wide linkage scan for gene controlling variation in urinary albumin excretion in type II diabetes. Kidney Int 69 : 129 136, 2006
19. Freedman BI, Beck SR, Rich SS, Heiss G, Lewis CE, Turner S, Province MA, Schwander KL, Arnett DK, Mellen BG : A genome-wide scan for urinary albumin excretion in hypertensive families. Hypertension 42 : 291 296, 2003
20. Mogensen CE, Vestbo E, Poulsen PL, Christiansen C, Damsgaard EM, Eiskjaer H, Froland A, Hansen KW, Nielsen S, Pedersen MM : Microalbuminuria and potential confounders. A review and some observations on variability of urinary albumin excretion. Diabetes Care 18 : 572 581, 1995
21. Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS : Regression of microalbuminuria in type 1 diabetes. N Engl J Med 348 : 2285 2293, 2003
22. Garg JP, Bakris GL : Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease. Vasc Med 7 : 35 43, 2002
23. Fox CS, Yang Q, Cupples LA, Guo CY, Larson MG, Leip EP, Wilson PW, Levy D : Genomewide linkage analysis to serum creatinine, GFR, and creatinine clearance in a community-based population: the Framingham Heart Study. J Am Soc Nephrol 15 : 2457 2461, 2004
24. Leon JM, Freedman BI, Miller MB, North KE, Hunt SC, Eckfeldt JH, Lewis CE, Kraja A, Djousse L, Arnett DK : Genome scan of glomerular filtration rate and albuminuria: the HyperGEN Study. Nephrol Dial Transplant 22 : 763 771, 2007
25. Imperatore G, Knowler WC, Pettitt DJ, Kobes S, Bennett PH, Hanson RL : Segregation analysis of diabetic nephropathy in Pima Indians. Diabetes 49 : 1049 1056, 2000
26. Satko SG, Langefeld CD, Daeihagh PD, Bowden DW, Rich SS, Freedman BI : Nephropathy in siblings of African-Americans with overt type 2 diabetic nephropathy. Am J Kidney Dis 40 : 489 494, 2002
27. Ferguson RM, Grim CE, Opgenorth TJ : A familial risk of chronic renal failure among blacks on dialysis? J Clin Epidemiol 41 : 1189 1196, 1988
28. Freedman BI, Spray BJ, Tuttle AB, Buckalew VM : The familial risk of end-stage renal disease in African Americans. Am J Kidney Dis 21 : 387 393, 1993
29. Lei HH, Perneger TV, Klag MJ : Familial aggregation of renal disease in a population-based case-control study. J Am Soc Nephrol 9 : 1270 1276, 1998
30. Freedman BI, Wilson CH, Spray BJ : Familial clustering of end-stage renal disease in blacks with lupus nephritis. Am J Kidney Dis 29 : 729 732, 1997
31. Freedman BI, Soucie JM, Stone SM, Pegram S : Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy. Am J Kidney Dis 34 : 254 258, 1999
32. Freedman BI, Volkova NV, Satko SG, Krisher J, Jurkovitz C, Soucie JM, McClellan WM : Population-based screening for family history of end-stage renal disease among incident dialysis patients. Am J Nephrol 25 : 529 535, 2005
33. Freedman BI, Soucie JM, McClellan W : Family history of end-stage renal disease among incident dialysis patients. J Am Soc Nephol 8 : 1942 1945, 1997
34. Barbari A, Stephan A, Masri M : Consanguinity-associated kidney diseases in Lebanon: an epidemiological study. Mol Immunol 39 : 1109 1114, 2003
35. Gumprecht J, Zychma MJ, Moczulski DK : Family history of end-stage renal disease among hemodialyzed patients in Poland. J Nephrol 16 : 511 515, 2003
36. Newsome B, McClellan W, McClure L, Howard G, Howard V, Warnock D : Characteristics and prevalence of kidney disease among adults with a family history of end-stage renal disease (ESRD). J Am Soc Nephol 17 : 203A, 2006 (Abstract)
37. Freedman BI, Soucie JM, Kenderes B, Krisher J, Garrett LE, Caruana R, McClellan WM : Family history of end-stage renal disease does not predict dialytic survival. Am J Kidney Dis 38 : 547 552, 2001
38. Scolari F, Amoroso A, Savoldi S, Mazzola G, Prati E, Valzorio B, Viola BF, Nicola B, Movilli E, Sandrini M, Campanini M, Majorca R : Familial clustering of IgA nephropathy: further evidence in an Italian population. Am J Kidney Dis 33 : 857 865, 1999
39. Harjutsalo V, Katoh S, Sarti C, Tajima N, Tuomilehto J : Population-based assessment of familial clustering of diabetic nephropathy in type 1 diabetes. Diabetes 53 : 2449 2454, 2004
40. Agius E, Attard G, Shakespeare L, Clark P, Vidya MA, Hattersley AT, Fava S : Familial factors in diabetic nephropathy: an offspring study. Diabet Med 23 : 331 334, 2006
41. Strojek K, Grzeszczak W, Morawin E, Adamski M, Lacka B, Rudzki H, Schmidt S, Keller C, Ritz E : Nephropathy of type II diabetes: evidence for heredity factors? Kidney Int 51 : 1602 1607, 1997
42. Fioretto P, Steffes MW, Barboso J, Rich SS, Miller ME, Mauer M : Is diabetic nephropathy inherited? Studies of glomerular structure in type 1 diabetic sibling pairs. Diabetes 48 : 865 869, 1999
43. Vijay V, Snehalatha C, Shina K, Lalitha S, Ramachandran A : Familial aggregation of diabetic kidney disease in type 2 diabetes in south India. Diabetes Res Clin Pract 43 : 167 171, 1999
44. Canani L, Gerchman F, Gross JL : Increased familial history of arterial hypertension, coronary heart disease, and renal disease in Brazilian type 2 diabetic patients with diabetic nephropathy. Diabetes Care 21 : 1545 1550, 1998
45. Ramirez SPB, McClellan W, Port FK, Hsu SIH : Risk factors for proteinuria in a large, multiracial, Southeast Asian population. J Am Soc Nephrol 13 : 1907 1917, 2002
46. Speckman RA, McClellan WM, Volkova NV, Jurkovitz CT, Satko SG, Schoolwerth AC, Freedman BI : Obesity is associated with family history of ESRD in incident dialysis patients. Am J Kidney Dis 48 : 50 58, 2006
47. Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S : Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 65 : 1870 1876, 2004
48. Freedman BI, Langefeld CD, Rich SS, Vails CJ, Sale MM, Williams AH, Brown WM, Beck SR, Hicks PJ, Bowden DW : A genome wide scan for end-stage renal disease in African Americans enriched for non-diabetic nephropathy. J Am Soc Nephol 15 : 2719 2727, 2004
49. Fan ZJ, Lackland DT, Kenderes B, Krisher J, Freedman BI : Impact of birth weight on familial aggregation of end-stage renal disease. Am J Nephrol 23 : 117 120, 2003
50. Lackland DT, Bendall HE, Osmond C, Egan BM, Barker DJP : Low birth weights contribute to the high rates of early-onset chronic renal failure in the southeastern United States. Arch Intern Med 160 : 1472 1476, 2000
51. Brown WW, Collins A, Chen SC, King K, Molony DA, Gannon M : Identification of persons at high risk for kidney disease via targeted screening: the NKF Kidney Early Evaluation Program. Kidney Int 63 : S50 S55, 2003
52. McGill JB, Brown WW, Chen SC, Collins AJ, Gannon M : Kidney Early Evaluation Program (KEEP). Findings from a community screening program. Diabetes Educ 30 : 196 202, 2004
53. Coresh J, Astor B, Greene T, Ecknoyan G, Levey AS : Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41 : 1 12, 2003
54. Freedman BI, Bowden DW, Sale MM, Langefeld CD, Rich SS : Genetic susceptibility contributes to renal and cardiovascular complications of type 2 diabetes mellitus. Hypertension 48 : 8 13, 2006
55. Shulman NB, Ford CE, Hall W, Blaufox MD, Simon D, Langford HG, Schneider KA : Prognostic value of serum creatinine and effect of treatment of hypertensionon renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 13 : I80 I93, 1989
56. McClellan WM, Warnock DG, McClure L, Campbell RC, Newsome BB : Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic And Racial Differences in Stroke (REGARDS) cohort study. J Am Soc Nephrol 17 : 1710 1715, 2006
57. Knowler WC, Coresh J, Elston RC, Freedman BI, Iyengar SK, Kimmel PL, Olson JM, Plaetke R, Sedor JR, Seldin MR, Family Investigation of Nephropathy and Diabetes Research Group : The Family Investigation of Nephrology and Diabetes (FIND): design and methods. J Diabetes Complications 19 : 1 9, 2005
58. The Family Investigation of Nephropathy and Diabetes Research Group : Genetic determinants of diabetic nephropathy: The family investigators of nephropathy and diabetes (FIND). J Am Soc Nephrol 14 (Suppl. 2 S202 S204, 2003
59. Genetics of Kidneys in Diabetes Study: Manual of Operations, 2002. http://www.gokind.org/about.html. (Computer Program), accessed March 15, 2007
60. Mueller PW, Rogus JJ, Clearly PA, Zhao Y, Smiles AM, Steffes MW, Bucksa J, Gibson TB, Cordovado SK, Krolewski AS, Nierras CR, Warram JH : Genetics of Kidneys in Diabetes (GoKinD) study: a genetics collection available for identifying genetic susceptibility factors for diabetic nephropathy in type 1 diabetes. J Am Soc Nephrol 17 : 1782 1790, 2006
61. Patel A, Scott WR, Lympany PA, Rippin JD, Gill GV : The TGF-B1 codon 10 polymorphism contributes to the genetic predisposition to nephropathy in type 1 diabetes. Diabet Med 22 : 69 73, 2005
62. Moczulski DK, Rogus JJ, Antonellis A, Warram JH : Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib-pair analysis. Diabetes 47 : 1164 1169, 1998
63. Osterholm AM, He B, Pitkaniemi J, Albinsson L, Berg T, Sarti C, Tuomilehto J, Tryggvason K : Genome-wide scan for type 1 diabetic nephropathy in the Finnish population reveals suggestive linkage to a single locus on chromosome 3q. Kidney Int 71 : 140 145, 2007
64. Ewens KG, George RA, Sharma K, Ziyadeh FN, Spielman RS : Assessment of 115 candiate genes for diabetic nephropathy by transmission/disequilibrium test. Diabetes 54 : 3305 3318, 2005
65. Bowden DW, Colicigno CJ, Langefeld CD, Sale MM, Williams A, Anderson PJ, Rich SS, Freedman BI : A genome scan for diabetes associated end-stage renal disease in African Americans. Kidney Int 66 : 1517 1526, 2004
66. Vionnet N, Tregouet D, Kazeem G, Gut I, Groop PH, Tarnow L, Parving HH, Hadjadj S, Forsblom M, Farrall M, Gauguier D, Cox R, Matsuda F, Heath S, Thevard A, Rousseau R, Cambein F, Marre M, Lathrop M : Analysis of 14 candidate genes for diabetic nephropathy on chromosome 3q in European populations: strongest evidence for association witha variant in the promoter region of the adiponectin gene. Diabetes 55 : 3166 3174, 2006
67. Vardarli I, Baier L, Hanson JA, Akkoyum I, Fischer C, Rohmeiss P, Bartram C, Van Der Woude F, Janssen B : Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23. Kidney Int 62 : 2176 2183, 2002
68. Iyengar SK, Freedman BI, The FIND Consortium : Genome-wide scans for diabetic nephropathy and proteinuria: the family investigation of nephropathy and diabetes (FIND). J Am Soc Nephrol 16 : 93A, 2005
69. Janssen B, Hohenadel D, Brinkkoetter P, Peters V, Rind N, Fischer C, Rychlik I, Cerna M, Romzova M, deHeer F, Baelde H, Bakker S, Zirie M, Rondeau E, Mathieson P, Saleem M, Meyer J, Koppel H, Sauerhoefer S, Bartram C, Nawroth P, Hammes HP, Yard B, Zschocke J, Van Der Woude F : Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1. Diabetes 54 : 2320 2307, 2005
70. Freedman BI, Hicks PJ, Sale MM, Pierson ED, Langefeld CD, Rich SS, Xu J, McDonough C, Janssen B, Yard BA, Van Der Woude F, Bowden DW : A leucine repeat in the carnosinase gene CNDP1 is associated with diabetic end-stage renal disease in European Americans. Nephrol Dial Transplant Jan 5, 2007
71. Boger CA, Fischereder M, Deinzer M, Aslanidis C, Schmitz G : RANTES gene polymorphisms predict all-cause and cardiac mortality in type 2 diabetes mellitus hemodialysis patients. Atherosclerosis 183 : 121 129, 2005
72. Losito A, Kalidas K, Santoni S, Errico R, Jerrery S : Association of the -159C/T polymorphism of the endotoxin receptor (CD14) with carotid artery disease and cardiovascular mortality in dialysis patients. Blood Purif 23 : 128 133, 2005
73. Raizada V, Skipper B, Luo W, Garza L, Hines CW : Renin-angiotensin polymorphisms and QTc interval prolongation in end-stage renal disease. Kidney Int 68 : 1186 1189, 2005
74. Jurkovitz C, Hylton TN, McClellan WM : Prevalence of family history of kidney disease and perception of risk for kidney disease: a population based study. Am J Kidney Dis 46 : 11 17, 2005
75. Lea JP, McClellan WM, Melcher C, Gladstone E, Hostetter T : CKD risk factors reported by primary care physicians: do guidelines make a difference? Am J Kidney Dis 47 : 72 77, 2006
76. Spray BJ, Atassi NG, Tuttle AB, Freedman BI : Familial risk, age at onset, and cause of end-stage renal disease in white Americans. J Am Soc Nephol 5 : 1806 1810, 1995
77. Pettitt DJ, Saad MF, Bennett PH : Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin dependent) diabetes mellitus. Diabetologia 33 : 438 443, 1990
78. Pugh J : Diabetic nephropathy and end-stage renal disease in Mexican Americans. Blood Purif 14 : 286 292, 1996
79. Seaquist ER, Goetz FC, Rich SS, Barboso J : Familial clustering of diabetic kidney disease: Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320 : 1161 1165, 1989
80. Freedman BI, Tuttle AB, Spray BJ : Familial predisposition to nephropathy in African-Americans with non-insulin dependent diabetes mellitus. Am J Kidney Dis 25 : 710 713, 1995
81. Bergman R, Key BO, Kirk KA : Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease. Am J Kidney Dis 27 : 341 346, 1996